what glp 1 does noom offer Med π¨ INTRODUCING: Noom Proactive Health
Description
Seek guidance first
Pregnancy Planning Retatrutide is contraindicated during pregnancy and breastfeeding
GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)
The number of uninsured patients without diabetes on these medications, along with those with insurance but who choose to pay out of pocket, is likely high
